Glucagon-like peptide-1 (GLP-1) peptides have emerged as a compelling therapeutic avenue for managing metabolic syndromes. These naturally occurring molecules are secreted by the gut in response to meal intake, https://my-social-box.com/story5913334/unveiling-the-therapeutic-potential-of-glp-1-peptides